Nrf2 in toxic models of degenerative disorders: an approache to Parkinson's and huntington's disease

被引：0
|
作者：
Ali, S. F. [1 ]
Tobon-Velasco, J. C. [2 ,3 ]
Pedraza-Chaverri, J. [3 ]
Cuadrado, A. [4 ]
Maldonado, P. D. [2 ]
Santamaria, A. [1 ,2 ]
机构：
[1] NCTR, Div Neurotox, Neurochem Lab, Jefferson, AR USA
[2] MVS SSA, Inst Nacl Neurol & Neurocirugia, Lab Aminoacids Excitadores, Mexico City, DF, Mexico
[3] Univ Nacl Autonoma Mexico, Dept Biol, Fac Quim, Mexico City, DF, Mexico
[4] Inst Invest Biomedades, Madrid, Spain
来源：
JOURNAL OF NEUROCHEMISTRY | 2013年 / 125卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [31] Pinostrobin Exerts Neuroprotective Actions in Neurotoxin-Induced Parkinson's Disease Models through Nrf2 Induction
    Li, Chuwen
    Tang, Benqin
    Feng, Yu
    Tang, Fan
    Hoi, Maggie Pui-Man
    Su, Ziren
    Lee, Simon Ming-Yuen
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2018, 66 (31) : 8307 - 8318
  • [32] Biomarkers in Huntington's and Parkinson's Disease
    O'Keeffe, Grainne C.
    Michell, Andrew W.
    Barker, Roger A.
    BIOMARKERS IN BRAIN DISEASE, 2009, 1180 : 97 - 110
  • [33] Improved Mathematical Models of Parkinson's Disease with Hopf Bifurcation and Huntington's Disease with Chaos
    Elfouly, M. A.
    ACTA BIOTHEORETICA, 2024, 72 (03)
  • [34] Formononetin Exerts Neuroprotection in Parkinson's Disease via the Activation of the Nrf2 Signaling Pathway
    Wang, Xiaotong
    Kang, Nianxin
    Liu, Ying
    Xu, Guojie
    MOLECULES, 2024, 29 (22):
  • [35] Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of Parkinson's disease
    Choi, Ji Won
    Kim, Siwon
    Yoo, Jong Seok
    Kim, Hyeon Jeong
    Kim, Hyeon Ji
    Kim, Byung Eun
    Lee, Elijah Hwejin
    Lee, Yong Sup
    Park, Jong-Hyun
    Park, Ki Duk
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 212
  • [36] Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease
    Lastres-Becker, Isabel
    Garcia-Yague, Angel J.
    Scannevin, Robert H.
    Casarejos, Maria J.
    Kuegler, Sebastian
    Rabano, Alberto
    Cuadrado, Antonio
    ANTIOXIDANTS & REDOX SIGNALING, 2016, 25 (02) : 61 - 77
  • [37] Neuroprotective effect of matrine on MPTP-induced Parkinson's disease and on Nrf2 expression
    Meng, Fanhua
    Wang, Jianhui
    Ding, Fuxiang
    Xie, Yunliang
    Zhang, Yingjie
    Zhu, Jie
    ONCOLOGY LETTERS, 2017, 13 (01) : 296 - 300
  • [38] The Research Progress of Nrf2 in Alzheimer's Disease
    Cao Hui-Min
    Yu Gang
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2015, 42 (06) : 533 - 539
  • [39] Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer's Disease
    Villavicencio Tejo, Francisca
    Quintanilla, Rodrigo A.
    ANTIOXIDANTS, 2021, 10 (07)
  • [40] THERAPEUTIC TARGETING OF NRF2 IN ALZHEIMER'S DISEASE
    Carnicero-Senabre, Daniel
    Barata, Mariana A.
    Almeida, Claudia Guimas
    Cuadrado, Antonio
    Rojo, Ana I.
    FREE RADICAL BIOLOGY AND MEDICINE, 2024, 218 : 3 - 3
12345